CR HOLDINGS (01911): China Renaissance Pan-Asia Successfully Assists AlphaPai, an AI Application Focused on Financial Scenarios, in Completing Its Latest Series B Financing
CR HOLDINGS (01911) announces that China Renaissance Pan-Asia Investment Advisory (Beijing) Co., Ltd. (China Renaissance Pan-Asia), an indirectly wholly-owned subsidiary of the Company, acted as the exclusive financial advisor for the transaction and successfully assisted AlphaPai, an AI application focused on financial scenarios, in completing its latest Series B financing.
CR HOLDINGS (01911) announced that China Renaissance Pan-Asia Investment Advisory (Beijing) Co., Ltd. (China Renaissance Pan-Asia), an indirectly wholly-owned subsidiary of the Company, acted as the exclusive financial advisor for this transaction and successfully assisted AlphaPai, an AI application focused on financial scenarios, in completing its latest Series B financing.
This round of financing received support from multiple types of investors, with investors spanning insurance funds, securities firms, industrial capital, leading venture capital institutions, and continued support from several existing shareholders. Following this round of financing, AlphaPai will continue to increase its investment in model and product technology, expand its multi-asset client base, deepen upstream and downstream industrial collaboration, and steadily advance its overseas layout while deepening its presence in the domestic market.
AlphaPai was built by Xuntu Technology, a leading enterprise in China's financial AI sector. It entered through high-frequency gateways such as meetings and information processing, and has gradually deepened into core investment research workflows including research, analysis, and knowledge accumulation. According to its public disclosures, AlphaPai currently serves over 120,000 professional users, covering more than 8,000 financial, asset management, and other institutions.
The appointment of China Renaissance Pan-Asia as the exclusive financial advisor demonstrates the Group's professional capabilities in financial advisory services in the AI and fintech sectors, as well as its deep client accumulation across the upstream and downstream of the financial and AI industry chains. It also reflects the Group's ability and credibility in continuously empowering innovative enterprises and assisting clients in achieving their strategic and financial goals. The Group is honored to assist AlphaPai in completing this round of financing and remains firmly optimistic about its long-term development potential in the financial AI and global financial services sectors.
Related Articles

C-MER MEDICAL (03309) repurchased 110,000 shares for HK$92,300 on September 14.

ZERO2IPO (01945) repurchased 6,800 shares for HKD 8,936 on September 14.

NEWBORNTOWN (09911) repurchased 208,000 shares on September 14 for approximately HK$1.9671 million.
C-MER MEDICAL (03309) repurchased 110,000 shares for HK$92,300 on September 14.

ZERO2IPO (01945) repurchased 6,800 shares for HKD 8,936 on September 14.

NEWBORNTOWN (09911) repurchased 208,000 shares on September 14 for approximately HK$1.9671 million.

RECOMMEND





